Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatitis C Relapse”

39 trials

Showing 20 of 39 results

Large-scale testing (Phase 3)Study completedNCT01405937
What this trial is testing

Study of Vaniprevir Plus PegIntron®/Ribavirin in Japanese Participants With Chronic Hepatitis C Who Relapsed After Treatment (MK-7009-044)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 51
Large-scale testing (Phase 3)Study completedNCT01753557
What this trial is testing

Efficacy and Safety of MP-424, Peginterferon Alfa-2a (PEG-IFN Alfa-2a), and Ribavirin(RBV) in Treatment-Naïve or Relapsed Hepatitis C

Who this might be right for
Chronic Hepatitis C (CHC)
Tanabe Pharma Corporation 54
Large-scale testing (Phase 3)Study completedNCT03090035
What this trial is testing

Impact of Interleukin 28B (rs12979860) Genotype on Virological Responses Chronic Hepatitis C Treatment

Who this might be right for
Hepatitis CHepatitis C Relapse
Sheikh Zayed Medical College 98
Post-approval studies (Phase 4)Study completedNCT04695769
What this trial is testing

Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders

Who this might be right for
Chronic Hepatitis C
Helwan University 281
Post-approval studies (Phase 4)Study completedNCT00926614
What this trial is testing

Efficacy of Actos Lipitor Pegasys & Ribavirin in CHC GT 1 Patients Who Relapsed or Nonresponded to Peg/Riba

Who this might be right for
Hepatitis c
Brooke Army Medical Center 20
Early research (Phase 1)Study completedNCT00565539
What this trial is testing

Study of PEG-rIL-29 (or PEG-IFN Lambda) in Subjects With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C, Chronic
ZymoGenetics 56
Not applicableUnknownNCT04662138
What this trial is testing

Safety and Efficacy of Different Antiviral Regimens for Hepatitis C Virus Relapse

Who this might be right for
Hepatitis CRelapseAntivirals
Alexandria University 100
Testing effectiveness (Phase 2)Study completedNCT01183169
What this trial is testing

Efficacy and Safety of Adding Alisporivir (DEB025) to Peginterferon (IFN) Alfa-2a (Peg-IFN Alfa-2a) and Ribavirin in Chronic HCV Genotype 1 Patients Who Relapsed or Did Not Respond to Previous Treatment

Who this might be right for
Hepatitis C
Debiopharm International SA 459
Not applicableEnded earlyNCT03483987
What this trial is testing

Re-treatment of HCV Following DAA Failure

Who this might be right for
Chronic Hepatitis C
Sanjay Gandhi Postgraduate Institute of Medical Sciences 18
Not applicableWithdrawnNCT00704756
What this trial is testing

An Observational Study of Patients With Chronic Hepatitis C Undergoing Treatment With PegIntron and Rebetol in Clinical Practice in Belgium (Study P05494)(WITHDRAWN)

Who this might be right for
Hepatitis C, ChronicHepatitis C
Merck Sharp & Dohme LLC
Large-scale testing (Phase 3)UnknownNCT00299923
What this trial is testing

Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination Therapy

Who this might be right for
Hepatitis C, ChronicRelapse
University of Hamburg-Eppendorf 300
Large-scale testing (Phase 3)Study completedNCT01598090
What this trial is testing

Phase 3 Efficacy and Safety Study of Peginterferon Lambda-1a and Ribavirin With Telaprevir

Who this might be right for
Hepatitis C Virus
Bristol-Myers Squibb 881
Early research (Phase 1)WithdrawnNCT00255359
What this trial is testing

Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers

Who this might be right for
Chronic Hepatitis C Virus Infection
Hadassah Medical Organization 60
Not applicableEnded earlyNCT00725842
What this trial is testing

Relapse Rate in Hepatitis C Patients Treated With Peginterferon Alfa-2b Plus Ribavirin in Common Clinical Practice in France (P05484)(Completed)

Who this might be right for
Hepatitis CHepatitis C, Chronic
Merck Sharp & Dohme LLC 97
Testing effectiveness (Phase 2)Study completedNCT00735969
What this trial is testing

High-Dose Ribavirin and Peginterferon to Treat Chronic Hepatitis C Genotype 1

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 21
Not applicableStudy completedNCT03145844
What this trial is testing

Direct Acting Agents in Hepatitis C Patients

Who this might be right for
Hepatitis CHepatitis C RelapseHepatitis C Recurrent
Fehmi Tabak 2,700
Testing effectiveness (Phase 2)WithdrawnNCT01430000
What this trial is testing

Safety and Efficacy of Sustained Interferon Alfa 2b (INF) Therapy of Relapsing Hepatitis C (HCV) Patients Using InfraDure Biopump

Who this might be right for
Hepatitis C
Medgenics Medical Israel Ltd.
Not applicableStudy completedNCT00723645
What this trial is testing

Rate and Predictors of Relapse in the Treatment of Hepatitis C (Study P05181)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 279
Very early researchEnded earlyNCT00882193
What this trial is testing

Pilot Study of Betaine + Combination Antiviral Therapy for Chronic Hepatitis C Genotype 1 Non-responder/Relapsers

Who this might be right for
Chronic Hepatitis CGenotype 1Relapse
University of Nebraska 2
Testing effectiveness (Phase 2)Study completedNCT00983060
What this trial is testing

Adaptive-design Dose Finding Study to Assess the Antiviral Efficacy and Safety of NIM811 Administered in Combination With Standard of Care (SOC) in Relapsed Hepatitis C Virus 1 (HCV-1) Infected Patients

Who this might be right for
Chronic Hepatitis C Genotype-1 Relapse
Novartis Pharmaceuticals 59
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation